Waverley Pharma Inc. filed its Annual on Apr 29, 2022 for the period ending Dec 31, 2021. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | 0.00% | 0.00% | +40.00% |
06-20 | Waverley Pharma Inc. Elects James Kinley as Director | CI |
05-29 | Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+40.00% | 1.38M | |
+16.83% | 122B | |
+22.02% | 116B | |
+22.18% | 27.03B | |
-21.60% | 20.36B | |
-16.89% | 16.43B | |
-18.57% | 15.91B | |
-44.74% | 15.6B | |
+62.07% | 14.94B | |
+3.10% | 13.59B |
- Stock Market
- Equities
- WAVE Stock
- News Waverley Pharma Inc.
- Waverley Pharma Inc. Auditor Raises 'Going Concern' Doubt